1,314
Views
12
CrossRef citations to date
0
Altmetric
Commentary

Breaking the cycle of opioid use disorder with Ibogaine

, PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Matthias Luz & Deborah C. Mash. (2021) Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse. Expert Opinion on Drug Metabolism & Toxicology 17:9, pages 1019-1022.
Read now

Articles from other publishers (11)

Judit Biosca-Brull, Genis Ona, Lineth Alarcón-Franco & Maria Teresa Colomina. (2024) A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets. Translational Psychiatry 14:1.
Crossref
Alessio Mosca, Stefania Chiappini, Andrea Miuli, Gianluca Mancusi, Maria Chiara Santovito, Francesco Di Carlo, Mauro Pettorruso, John M. Corkery, Carlos Canessa, Giovanni Martinotti & Massimo Di Giannantonio. (2023) Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature. Current Neuropharmacology 21:11, pages 2178-2194.
Crossref
Genaro Herrera Cano, Jordan Dean, Samuel Padilla Abreu, Amanda Hernández Rodríguez, Cyrena Abbasi, Madison Hinson & Brandon Lucke-Wold. (2022) Key Characteristics and Development of Psychoceuticals: A Review. International Journal of Molecular Sciences 23:24, pages 15777.
Crossref
Bruno Ramos Gomes & Luis Fernando Tofoli. (2022) A sacred plant of neuronal effect: the use of ibogaine in addiction treatments in Brazil. Anthropology of Consciousness 33:2, pages 333-357.
Crossref
Patrick Köck, Katharina Froelich, Marc Walter, Undine Lang & Kenneth M. Dürsteler. (2022) A systematic literature review of clinical trials and therapeutic applications of ibogaine. Journal of Substance Abuse Treatment 138, pages 108717.
Crossref
Margarida L. F. Martins, Paniz Heydari, Wenlong Li, Alejandra Martínez-Chávez, Nikkie Venekamp, Maria C. Lebre, Luc Lucas, Jos H. Beijnen & Alfred H. Schinkel. (2022) Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites. Frontiers in Pharmacology 13.
Crossref
Martie S. Underwood, Stephen J. Bright & B. Les Lancaster. (2021) A narrative review of the pharmacological, cultural and psychological literature on ibogaine. Journal of Psychedelic Studies 5:1, pages 44-54.
Crossref
Michaela Barber, John Gardner, Michael Savic & Adrian Carter. (2020) Ibogaine therapy for addiction: Consumer views from online fora. International Journal of Drug Policy 83, pages 102857.
Crossref
Esther Blessing, Sanya Virani & John Rotrosen. 2020. Substance Use Disorders. Substance Use Disorders 167 202 .
Deborah C. Mash, Linda Duque, Bryan Page & Kathleen Allen-Ferdinand. (2018) Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes. Frontiers in Pharmacology 9.
Crossref
Thaddeus James Camlin, Donald Eulert, Arthur Thomas Horvath, Steven F. Bucky, Joseph P. Barsuglia & Martin Polanco. (2018) A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders. Journal of Psychedelic Studies 2:1, pages 24-35.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.